Diffusion et gestion de communiqués de presse

21 août 2024 07h00 HE | Source: Biostem Technologies

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje®

12 août 2024 16h14 HE | Source: Biostem Technologies

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

05 août 2024 08h00 HE | Source: Biostem Technologies

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

10 juil. 2024 07h15 HE | Source: Biostem Technologies

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers

26 juin 2024 08h30 HE | Source: Biostem Technologies

BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study

BioStem Technologies to Sponsor MRO Better Half Dash

29 mai 2024 11h00 HE | Source: Biostem Technologies

BioStem Technologies to Sponsor MRO Better Half Dash

14 mai 2024 16h01 HE | Source: Biostem Technologies

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million

07 mai 2024 08h00 HE | Source: Biostem Technologies

BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

06 mai 2024 08h00 HE | Source: Biostem Technologies

BioStem Technologies Granted Prioritized Examination for Wound Healing Patent

30 avr. 2024 08h30 HE | Source: Biostem Technologies

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

Souhaitez-vous accéder aux communiqués récents ?